一名无心脏病的儿科患者在长时间输注右美托咪定停药后出现室上性心动过速。
Supraventricular tachycardia after withdrawal of prolonged dexmedetomidine infusion in a paediatric patient without heart disease.
作者信息
Flores-González J Carlos, Estalella-Mendoza Ana, Lechuga-Sancho Alfonso M, Hernández-González Arturo, Rubio-Quiñones Fernando, Rodríguez-Campoy Patricia, Saldaña-Valderas Mónica
机构信息
Pediatric Intensivist, Pediatric Intensive Care Unit, Puerta del Mar University Hospital, Cádiz, Spain.
Pediatrics, Mother and Child Health, and Radiology Department, Cádiz University, Cádiz, Spain.
出版信息
J Clin Pharm Ther. 2017 Oct;42(5):653-655. doi: 10.1111/jcpt.12564. Epub 2017 May 27.
WHAT IS KNOWN AND OBJECTIVE
Dexmedetomidine (DEX) has been reported to be safe in paediatric patients.
CASE DESCRIPTION
We present the case of a girl without heart disease admitted at our PICU due to an influenza A acute respiratory distress syndrome, who suffered a paroxysmal supraventricular tachycardia (PSVT) twelve hours after DEX progressive withdrawal was completed.
WHAT IS NEW AND CONCLUSION
This is the first report of PSVT as an adverse reaction to DEX in a paediatric patient without heart disease.
已知信息与目的
据报道，右美托咪定（DEX）在儿科患者中是安全的。
病例描述
我们报告一例因甲型流感急性呼吸窘迫综合征入住我院儿科重症监护病房（PICU）的无心脏病女孩病例，该女孩在完成DEX逐渐撤药12小时后发生阵发性室上性心动过速（PSVT）。
新发现与结论
这是首例关于无心脏病儿科患者发生PSVT作为DEX不良反应的报告。
Zotero 插件